Smithers, a bioanalytical contract research organization (CRO), supports biologics development for any indication and has particular expertise in immuno-oncology assays. Smithers has developed and validated over 150 PK, ADA , fit-for-purpose biomarker and ligand binding and cell-based NAB assays supporting the development of therapeutic biologics.
Show Policy

Latest Resources

See all resources